|
|
Validity of the motor function measurement scale when routinely used in the follow-up of adult outpatients in a neuromuscular center
Date put on line :
10 January 2012
Between 2005 and 2007, among 100 adults (18-78y) with Steinert myotonic dystrophy or facio-scapulohuméral dystrophy randomly selected in reference center of Nice consultation, was collected: the MFM, the muscle testing of the limbs, face and spine, Brooke and Vignos scores. MFM scores were compared with other scores by Spearman correlation coefficient and principal component analysis. The results confirm the validity of the MFM in these pathologies. Therefore we recommend the routine use of 3 dimensions D1, D2 and D3, and for a more detailed analysis of the face and trunk, complete clinical evaluation by a muscle testing. (French article)
C. Benaïm, S. Sacconi, M. Fournier-Mehouas, V. Tanant , C. Desnuelle
|
|
173rd ENMC international workshop: Congenital muscular dystrophy outcome measures, 5-7 March 2010, Naarden, The Nertherlands
Date put on line :
19 August 2011
The workshop brought together 22 clinicians and experts from five countries to advance the implementation of suitable clinical outcome measures and endpoints specific for the CMDs to advance CMD clinical trial readiness.
Preliminary results of an MFM data review of 52 CMD patients comprising 41 patients age 6–72 years of age evaluated with the MFM32 and 11 children age 3–6 years evaluated with the MFM 20.
For CMD patients evaluated serially with the MFM (16 with MFM-32, 3 with MFM-20), individual curves show either a stable course or more often slow decline in score, depending on disease stage.
C.G. Bönnemann, A. Rutkowski, E. Mercuri, F. Muntoni, for the CMD Outcomes Consortium
|
|
Upper limb function in adults with Duchenne muscular dystrophy
Date put on line :
18 August 2011
This study illustrates a large variability in upper limb function in adult patients with Duchenne muscular dystrophy, and identifies muscle strength and range of motion as factors strongly associated with upper limb function.
These results suggest that preserving muscle strength and range of motion in Duchenne patients might be relevant for a better outcome of distal motor function of the upper limb when adult.
Bart Bartels, Robert F. Pangalila, Michael P. Bergen, Nicolle A. M. Cobben, Henk J. Stam, Marij E. Roebroeck
|
|
Muscular disability and organ impairments in myotonic dystrophy type 1
Date put on line :
18 August 2011
The purpose of this study, conducted among 69 patients with myotonic dystrophy type 1 was to assess the correlation between MFM score and some organ. MFM score appears as a good indicator for monitoring these patients. The occurrence of cataracts and heart and pulomnary damage are correlated with a decrease in score MFM.
L.Pruna, F. Machado, L. Louis, G. Vassé et P. Kaminsky
|
|
Regional Body composition and functional impairment in patients with Myotonic Dystrophy
Date put on line :
18 August 2011
In this study, fat-free mass index (FFMI), fat mass index (FMI) and functional impairment were examined in 48 patients with myotonic dystrophy type 1 subjects and anthropometrically matched control pairs.
Lelia PRUNA, Jérôme CHATELIN, Véronique PASCAL-VIGNERON, and Pierre KAMINSKY
|
|
ESCALA MEDIDA DA FUNÇÃO MOTORA (MFM): NOVO
Date put on line :
04 July 2011
objective of this study were: to translate the French version of Motor Function Measure (MFM) into the Portuguese language; to describe the inter and intraexaminer reliability of the Portuguese MFM version (P-MFM); to validate the PMFM in Brazilian patients with neuromuscular disease; to analyzed the applicability of the P-MFM in congenital fibre type disproportion (CFTD), associated with muscle magnetic resonance image, and in Myotonic Dystrophy type 1 (MD-1), correlating with the strength. Methods: for the accomplishment of the Portuguese MFM version scale, two MFM translations were produced separately by proficient neurologists in French, resulting in a consensual text after evaluation by authors.
Tese de Doutorado apresentada à Pós-Graduação da Faculdade de Ciências Médicas da Universidade Estadual, de Campinas para obtenção do título de Doutor em, Ciências Médicas, Área de Concentração Ciências Biomédicas.
Cristina IWABE
|
|
Progress usind the Motor Function Measure for NMDs
Date put on line :
01 December 2010
World Muscle Society octobre 2010 Kumamoto Japon
D. de Castro, C.Payan, C.Vuillerot, F.Girardot, C. Bérard ant the MFM Study Group
|
|
Validation of MFM-20, a short form of the Motor Function Measure for children between 2 and 7 years of age with neuromuscular disease
Date put on line :
30 November 2010
World Muscle Society october 2010 Kumamoto Japon
C.Payan, C. de Lattre, F. Girardot, C. Vuillerot, C. Bérard and the study group MFM
|
|
The Motor Function Measure, an outcome measure for neuromuscular disorders: Preliminary results in Congenital Muscular Dystrophy (DMC)
Date put on line :
30 November 2010
ICNMD Congress in Naples in July 2010
Authors of presented poster: C.Payan, D. de Castro, S. Quijano, T. Stojkovic, C.Bérard, B. Estournet and the study group MFM
|
|
The Motor Function Measure (MFM): Sensitivity to change World Muscle Society Geneve 2009 October 9-12
Date put on line :
08 September 2009
Authors of presented poster:
C Payan, C Vuillerot , J Fermanian, C. Bérard, and the MFM study Group.
|
|
Motor Function Measure: construction of a short form (MFM-20) World Muscle Society Geneve 2009 October 9-12
Date put on line :
08 September 2009
Authors of the poster :
C de Lattre, C Payan, C Payet, C Fafin, F Girardot, A Jouve.
|
|
Use of Motor Function Measure (MFM) to assess motor function ability in patients with Spinal Muscular Atrophy (SMA) World Muscle Society Geneve 2009 October 9-12
Date put on line :
08 September 2009
authors of presented poster
C. Vuillerot, C.Payan, C. Bérard and the MFM study group
|
|
Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure
Date put on line :
30 June 2009
Dev med Child Neurol.2009 April p 60-65
C.Vuillerot F.Girardot C.Payan J.Fermanian J.Iwac C.De Lattre C.Bérard
|
|
Motor Function Measure: portuguese versionand reliability analysis Iwabe C., Miranda-Pfeilsticker BH., Nucci A. Sept/Oct 2008
Date put on line :
08 March 2009
Abstract: Functional evaluation instruments for patients with neuromuscular disorders are rare. The Motor Function Measure (MFM) scale is available in the originale French version and in English and Spanish translations. Objective: to make a Portuguese translation of the MFM and to identify its intra and inter-examiner reliability.
Iwabe C., Miranda-Pfeilsticker BH., Nucci A.
|
|
Neuromuscular Disorders 2005;15:463-470
Date put on line :
29 March 2008
A motor function measure scale for neuromuscular diseases. Construction and validation study.
Bérard C, Payan C, Hodgkinson I, Fermanian J and the MFM collaborative study group.
|
|
Revue Neurologique 2006;162:485-493.
Date put on line :
29 March 2008
La mesure de fonction motrice, outil d’évaluation clinique des maladies neuromusculaires.
Etude de validation.
Bérard C, Payan C, Fermanian J, Girardot F et le groupe d’étude MFM.
|
|
|
|
|
|
|